Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Specialists discuss role of biosimilars in future of retinal disease management Michela Cimberle
-
- AI-based fluid activity meter drives breakthrough changes in management of neovascular AMD Michela Cimberle
- Case report: IOL with PMMA haptic tips may cause intraoperative posterior capsule rupture Jack S. Parker, MD, PhD; Yazen Shihab, BS; John S. Parker, MD
- FDA approves Cimerli as interchangeable biosimilar to Lucentis Anthony DeFino
- iStent infinite cleared by FDA Anthony DeFino
- Q&A: Five C’s help prevent, manage cataract surgery complications Eric D. Donnenfeld, MD; Michela Cimberle
- VIDEO: Laser scleral microporation presbyopia therapy on the horizon Mitchell A. Jackson, MD; David W. Mullin
- Seven characteristics of practices that thrive at any size John B. Pinto
- Semilunar sign on cornea a telltale sign of scleritis Dhivya Ashok Kumar, MD, FRCS, FICO, FAICO; Amar Agarwal, MS, FRCS, FRCOphth
-
- Woman presents with progressive left eye proptosis, upper lid edema Yi Ling Dai, MD; Laurel N. Vuong, MD
- Transition to ophthalmic biosimilars may be driven by cost Richard L. Lindstrom, MD
- Considering safety, effectiveness and cost, are you in favor of switching to biosimilars?